Mylan (MYL) volatile amid CEO interview on CNBC
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Mylan (NASDAQ: MYL) volatile amid CEO interview on CNBC. Last up 3.5%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Theravance Biopharma and Mylan Announce Positive Results from Two Pivotal Phase 3 Studies of Revefenacin (TD-4208) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
- B/E Aerospace (BEAV) volatility flat into deal with Rockwell Collins (ROK)
- Under Armour (UA) puts active onto Q3 and outlook
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!